Moderna expands beyond vaccines while Recursion bets on AI-driven drug discovery, each with distinct risks, partnerships, and financial profiles.
How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
The Council for the Indian School Certificate Examinations (CISCE) has released the ISC Computer Science (Subject Code - 868) for the Year 2027 evaluation cycle. It is designed specifically to make ...
Abstract: This paper proposes a new recursive implementation of the Gaussian filter. Previous recursive implementations of the Gaussian filter suffer from one or several drawbacks. Some methods ...
Autonomous AI post-training reached frontier scale for the first time: NVIDIA researchers published a paper showing an AI ...
The compiler infers, but does not take instructions. There is no syntax for explicit type declarations yet, and the new type ...
Recursion Pharmaceuticals combines artificial intelligence, automation, and biotechnology research across multiple ...
Abstract: This paper studies the control-oriented recursive identification of finite impulse response systems with binary-valued observations. Inspired by the Maximum Likelihood method, a novel ...
The loop takes agentic AI a step further by authorizing a swarm of agents to work continuously in the background, endlessly.
Ben Taylor, CFO of Recursion, here with us. Thanks so much for joining us. Sure. Great. And first of all, thanks for having us here, Tommie. This is always a terrific conference and great to be here.
The companies at the frontier of artificial intelligence should be ready to slow down, one of the fastest-moving among them says. Anthropic, the maker of the Claude chatbot, has claimed AI systems may ...
Recursive Superintelligence, founded by former Google, Meta and OpenAI researchers, is part of a growing effort to automate the creation of artificial intelligence. By Cade Metz Reporting from San ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果